Veronica Olavarria Selected Research

Factor Xa Inhibitors

12/2018

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veronica Olavarria Research Topics

Disease

2	Embolic Stroke 01/2021 - 12/2018
2	Ischemic Stroke 01/2021 - 12/2018
1	Embolism (Embolus) 01/2021
1	Hemorrhagic Stroke 01/2021
1	Cerebral Hemorrhage 01/2021
1	Stroke (Strokes) 12/2018
1	Patent Foramen Ovale 12/2018
1	Hemorrhage 12/2018

Drug/Important Bio-Agent (IBA)

2	RivaroxabanIBA 01/2021 - 12/2018
2	AnticoagulantsIBA 01/2021 - 12/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 12/2018
1	Factor Xa (Coagulation Factor Xa)IBA 01/2021
1	Factor Xa InhibitorsIBA 12/2018

Therapy/Procedure

2	Therapeutics 01/2021 - 12/2018